M. Vassilomanolakis

A phase II study of ondansetron as antiemetic prophylaxis in patients receiving high-dose polychemotherapy and stem cell transplantation

G. Koumakis, A. Efremidis, V. Barbounis, 1995, Supportive Care in Cancer.

Is weekly paclitaxel superior to paclitaxel given every 3 weeks? Results of a phase II trial.

G. Koumakis, A. Efremidis, V. Barbounis, 2002, Lung cancer.

Short communication Is weekly paclitaxel superior to paclitaxel given every 3 weeks? Results of a phase II trial

G. Koumakis, A. Efremidis, V. Barbounis, 2002 .